Low-molecular-weight heparin for thrombophilia in pregnant women.

@article{Bar2000LowmolecularweightHF,
  title={Low-molecular-weight heparin for thrombophilia in pregnant women.},
  author={J. Bar and Bina Cohen-Sacher and Moshe Hod and Dorith Blickstein and Judith Lahav and Paul L Merlob},
  journal={International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics},
  year={2000},
  volume={69 3},
  pages={209-13}
}
OBJECTIVE Low-molecular-weight heparin (LMWH) is the anticoagulant of choice during pregnancy because it is associated with a low incidence of osteoporosis and thrombocytopenia. Antithrombotic therapy has recently been used to prevent pregnancy loss in high-risk patients with evidence of acquired or congenital thrombophilia. The aim of the present study was to gain further information on the teratogenic potential of LMWH in this patient group. METHODS The study population included 46 patients… CONTINUE READING
8 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…